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The human cytomegalovirus UL34 gene represses expression of the US3 immune evasion gene and is essential for viral replication in cell
culture. Two highly related proteins, an early and a late protein, are synthesized at different times during infection from the UL34 gene. The late
protein differs from the early protein only by the omission of 21 amino terminal amino acids. Both UL34 proteins repress expression of the US3
promoter and bind specifically to a DNA element in the US3 gene. We have localized the DNA-binding domain of the UL34 open reading frame to
amino acids 22 to 243. Surprisingly, this same region of the UL34 open reading frame was also sufficient for transcriptional repression of US3
expression. The UL34 gene is unusual in encoding proteins that have extensively overlapping DNA-binding and transcriptional regulatory domains.
© 2006 Elsevier Inc. All rights reserved.Keywords: Human cytomegalovirus; UL34; DNA binding; Transcriptional repressionIntroduction
Human cytomegalovirus (HCMV) has a large genome with
the potential to encode over 220 proteins (Chee et al., 1990;
Davison et al., 2003). Expression of the viral genome occurs in
a coordinately regulated pattern throughout the five-day
replication cycle. Of the identified open reading frames in the
HCMV genome, a relatively small number (36 to 45 genes) are
essential for viral replication in cell culture (Dunn et al., 2003;
Murphy et al., 2004). The essential viral genes encode
transcription factors such as IE2, proteins needed for replication
of the viral genome, proteins that contribute to the structure of
the virion and proteins needed for virion egress. The functions
of other essential genes remain unknown.
The UL34 gene is essential for HCMV replication in cell
culture (Biegalke et al., 2004; Dunn et al., 2003; Murphy et al.,
2004). Although the role of UL34 in viral replication is not well
understood, its expression represses transcription of the HCMV⁎ Corresponding author. Department of Biomedical Sciences, Ohio University
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transcriptional repressive activity of UL34 proteins is mediated
through interactions with a specific DNA sequence element (the
transcriptional repressive element or tre) located between the
TATA box and the transcription start site in the US3 gene
(Biegalke, 1998; Biegalke et al., 2004).
The UL34 gene is expressed throughout the viral replication
cycle and encodes two highly related, yet distinct, proteins
(Biegalke et al., 2004). Early in infection, a 43 kDa UL34
protein is synthesized followed by a switch to synthesis of a 40
kDa UL34 protein later in infection. The late UL34 protein
(pUL3440kDa) lacks 21 residues that are present at the amino
terminus of the early protein; otherwise, the proteins are
identical. Both UL34 proteins localize to the nucleus and
repress US3 expression. The studies described here identify the
DNA-binding and transcriptional repressive domains of the
UL34 open reading frame.
Results
Computer analysis of the UL34 open reading frame
The UL34 open reading frame was analyzed for amino acid
content and predicted pI (isoelectric focusing point). As
28 E. Lester et al. / Virology 353 (2006) 27–34diagramed in Fig. 1B, the amino terminus (residues 1–220; Fig.
1B, white rectangle) is very basic in nature, with a predicted pI of
9.48, while the carboxyl terminus is acidic, with a predicted pI of
4.54, due in part to the presence of 3 short acidic amino acid
clusters (Fig. 1B). Twenty percent of the carboxyl terminal 34
amino acids is comprised of proline residues. Although two
nuclear localization signals were predicted to be present in the
UL34 open reading frame, with one located in each half of the
open reading frame (Fig. 1B; PSORTII; http://psort.ims.u-tokyo.
ac.jp/), immunofluorescent UL34 antibody staining demonstrat-
ed that no nuclear localization signal was present in the amino
terminal half of the protein (data not show). Analogy to otherFig. 1. Identification of the DNA-binding domain of pUL34. (A) Electrophoretic mo
open reading frame were constructed, and proteins synthesized using in vitro transc
binding site in the US3 gene was assayed by non-denaturing gel electrophoresis. The
3, luciferase; lane 4, UL34 amino acids 22–231; lane 5, UL34 amino acids 28–407; la
amino acids 1–246; lane 9, UL34 amino acids 22–407; lane 10, UL34 amino acids 28
(B) Diagram of the UL34 open reading frame. The amino terminal half of the protein
carboxyl terminal half is very acidic (predicted pI value of 4.54, medium gray recta
lines), as are the acidic amino acid clusters (light gray rectangles) and the proline-rich
indicate the amino and the carboxyl terminal boundaries of the DNA binding domai
amino acid residues in each indicated by the numbers. The ability of the protein totranscription factors suggested that the amino terminal half of the
UL34 open reading frame should comprise the DNA-binding
domain of the protein while the carboxyl terminal half was
predicted to contain the transcriptional regulatory domain.
Localization of the DNA-binding domain of pUL34
The DNA-binding domain of the UL34 open reading frame
was identified using electrophoretic mobility shift assays
(EMSAs) and in vitro synthesized UL34 proteins. Plasmids
were constructed so that portions of the UL34 open reading
frame could be expressed as proteins, using in vitro transcription/bility shift analysis of UL34 peptides. Plasmids expressing portions of the UL34
ription/translation reactions. The ability of the proteins to interact with pUL34
proteins assayed are: lane 1, probe alone; lanes 2 and 11, full-length pUL34; lane
ne 6, UL34 amino acids 22–389; lane 7, UL34 amino acids 1–231; lane 8, UL34
–389; and lane 12, UL34 amino acids 1–243. The unbound probe is indicated, *.
is very basic (as indicated by the predicted pI value of 9.48, white rectangle); the
ngle). The predicted nuclear localization signals are indicated (black horizontal
carboxyl terminal end (cross-hatched rectangle). The vertical line and the arrow
n, respectively. (C) Diagram of the different forms of the UL34 protein with the
bind DNA is indicated as is the plasmid number.
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open reading frame was deleted, a consensus ATG was added
during plasmid construction to provide a translation initiation
codon. Protein synthesis was monitored by including 35S-
methionine in the translation reactions followed by polyacryl-
amide gel electrophoresis. Although the number of methionine
residues and the translation efficiencies for the different portions
of the UL34 open reading frame varied, translation products
corresponding to the predicted sizes of the truncated UL34
proteins were detected following autoradiography of the protein
gels (data not shown). The DNA probe used in the EMSAs was
comprised of the US3 transcriptional repressive element (tre)
which was previously shown to interact specifically with
pUL34 (LaPierre and Biegalke, 2001). In vitro synthesized
UL34 proteins or the control protein luciferase were incubated
with the 32P-labeled tre followed by electrophoresis on native
polyacrylamide gels.
Both the early (amino acids 1–407) and late UL34 proteins
(amino acids 22 to 407) interacted specifically with the tre in
EMSAs as evidenced by the decrease in the migration rate of the
radiolabeled DNA probe, as previously shown (Fig. 1A;
Biegalke et al., 2004). Thus, the interaction of the late protein
with the tre demonstrates that the first 21 amino acids of the
UL34 open reading frame are not required for DNA binding
activity. Additional truncated versions of the UL34 proteins
were tested to localize the region necessary for DNA-binding
activity. A protein comprised of amino acids 28 to 407 was
unable to bind to the DNA probe (Fig. 1A); consequently, the
amino terminal boundary for DNA-binding activity resides
between residues 22 and 28. Pending additional mapping of the
contributions of amino acids 22 to 30 to DNA-binding activity,
amino acid 22 is defined as the amino terminal boundary of the
DNA-binding domain.
The carboxyl terminal boundary of the DNA-binding
domain of pUL34 was localized in a similar manner. Since a
truncated protein comprised of amino acids 1 to 243 was able to
bind the DNA probe while a protein comprised of amino acids 1
to 231 lacked DNA-binding activity (Fig. 1A), the carboxyl
terminal boundary of the UL34 DNA-binding domain resides
between residues 231 and 243.
The localization of the DNA-binding domain of UL34
between amino acids 22 and 243 is supported by the
observation that a protein comprised of amino acids 22–389
was also able to bind the DNA probe (Fig. 1A, lane 6). The
decrease in intensity of the DNA–protein complexes seen in
lane 6 is a result of a reduction in the amount of protein present
in the binding reaction (data not shown). UL34 proteins
comprised of amino acid 22 to 231 or 28 to 389 were unable to
bind DNA (Fig. 1A, lanes 4 and 10). The negative control
protein luciferase was also synthesized using in vitro transcrip-
tion/translation reactions and did not form a DNA–protein
complex (luc, Fig. 1A, lane 3). The results of the experiments
identifying the DNA-binding domain of the UL34 open reading
frame are summarized in Fig. 1C. In summary, UL34 amino
acids 22 to 243 are sufficient for specific DNA-binding activity,
corresponding to the predicted role of the basic amino terminal
portion of the UL34 open reading frame.Transcriptional repressive activity of UL34
Because many transcription factors are comprised of discrete
domains, the amino acid analysis of the UL34 open reading
frame and the identification of the amino terminal DNA-binding
domain suggested that the carboxyl terminal half of the protein
would likely comprise the transcriptional regulatory domain.
Further analyses of the UL34 protein, however, were compli-
cated because of the necessity of retaining an intact DNA-
binding domain and a nuclear localization signal. To surmount
this problem, we constructed plasmids that expressed portions
of the UL34 open reading frame as in-frame fusion proteins
with the DNA-binding domain (DBD) of the yeast transcription
factor GAL4. To assess the function of GAL4-DBD-UL34
fusion proteins, we also constructed a new reporter plasmid,
substituting the GAL4-binding site for the UL34 binding site in
the US3 regulatory region in the lacZ reporter gene plasmid
pBJ171 (Fig. 2A; Biegalke, 1998). The plasmids expressing
GAL4-DBD-UL34 fusion proteins were used in transient
transfection assays, in combination with the reporter gene
plasmid containing a GAL4-binding site, to identify the
transcriptional regulatory domain of the UL34 open reading
frame. The plasmids expressing the UL34 open reading frame
were transfected into human fibroblasts along with a plasmid
expressing the HCMV IE1 and IE2 proteins. The relative
amounts of β-galactosidase produced were determined by
measuring the fluorescence of the cleavage product of
methylumbelliferyl β-D-galactoside (MUG). Immunofluores-
cence experiments demonstrated that all of the GAL4-DBD-
UL34 fusion proteins localized to nuclei of transfected cells
(data not shown).
The initial experiments examined the functionality of the
GAL4-DBD-UL34 fusion proteins. The activity of pUL34 was
compared with that of the GAL4-DBD-UL34 fusion protein. As
depicted in Fig. 2B, expression of the GAL4-DBD alone had no
repressive activity on the US3 promoter in the context of a
UL34 binding site. In contrast, the GAL4-DBD-UL34 fusion
protein was as efficient as pUL34 alone in repressing the US3
promoter (Fig. 2B), demonstrating that the addition of the
GAL4-DBD to UL34 did not interfere with the repressive
activity of UL34.
The UL34- and the GAL4-DBD-UL34 expression constructs
were then assayed for activity on the reporter plasmid
containing a GAL4-binding site substituted for the pUL34
binding site. Neither pUL34 nor the GAL4-DBD alone was able
to repress expression of the plasmid containing the GAL4-
binding site (Fig. 2B); however, the GAL4-DBD-UL34 fusion
protein was very efficient at repressing transcription of the US3
promoter in the context of a GAL4-binding site (Fig. 2B). This
observation demonstrated that the GAL4 system could be used
to define the transcriptional repression domain of pUL34. The
negative control, a plasmid transcribing the UL34 gene in an
anti-sense direction, had no effect on gene expression.
In the course of analyzing the effects of the GAL4-DBD-
UL34 fusion protein on reporter gene activity, we observed that
mutating the UL34 binding site to a GAL4-binding site
significantly reduced the level of reporter gene activity seen
Fig. 2. Analysis of GAL4 DBD-UL34 fusion proteins. (A) Sequence of the US3 TATA box and the UL34 binding site (underlined); the GAL4-binding site substituted
for the UL34 binding site in the lacZ reporter gene plasmid is shown below the UL34 binding site (lowercase letters). (B) Analysis of the activity of the GAL4 DBD-
UL34 fusion proteins. The binding site for the GAL4 DBD or pUL34 present in the reporter constructs is indicated. Plasmids encoding the indicated proteins were
transfected into primary human diploid fibroblasts, along with either pBJ171, the US3-tre reporter gene plasmid (containing a UL34 binding site), or with BJ555, the
US3-GAL4-binding site-reporter gene plasmid, in the presence of the HCMVmajor immediate early proteins, IE1 and IE1. The fusion protein comprised of the GAL4-
DBD fused to UL34 amino acids 222–407 is encoded by pBJ539. (C) Analysis of the effects of IE1, IE2 or IE1 and IE2 on the relative levels of expression from the
reporter constructs that contain a UL34 or a GAL4-binding site. The fluorescence of media containing the cleavage product of 5 methylumbelliferyl-β-D-galactoside
(MUG) was measured as an indication of reporter gene transcription. The transfection assays were repeated multiple times; the results depicted are the average of two
experiments, with one standard deviation. Background levels of fluorescence obtained with the promoterless control plasmid pEQ3 were subtracted from the values
obtained with the US3 promoter–reporter plasmid.
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IE1 and IE2 (Fig. 2B). To determine the basis of the reduced
level of reporter gene activity, we compared the responses of the
reporter plasmids which contained either a UL34 binding site or
a GAL4-binding site to the major immediate early proteins, both
singly and in combination. As seen in Fig. 2C, substitution of aGAL4-binding site for the UL34 binding site significantly
decreased IE2 activation of the US3 promoter. In contrast, levels
of expression seen with IE1 alone were similar for both reporter
constructs. The marked decrease in IE2 activation of the US3
promoter following mutation of the UL34 binding site is of note
as previous studies suggested that IE2 would bind to this region
31E. Lester et al. / Virology 353 (2006) 27–34(Biegalke, 1997, 1998; Thrower et al., 1996). These results
support the idea that IE2 activates US3 expression by
interacting with sequences located between the transcription
start site and the TATA box.
Using GAL4-DBD-UL34 fusion constructs, we asked
whether the carboxyl terminal half of pUL34 alone, when
fused to a heterologous DNA-binding domain, was sufficient to
mediate transcriptional repression by binding to the
corresponding DNA element. A construct expressing UL34
amino acids 222 to 407 as a GAL4-DBD fusion protein
(pBJ539; Fig. 2B) was analyzed for effects on expression of the
US3 promoter paired with a GAL4-binding site. The fusion
protein showed no repressive activity (Fig. 2B), contradicting
the prediction that the carboxyl terminal half of pUL34 alone
would be sufficient for transcriptional regulatory activity.
The region of the UL34 open reading frame necessary and
sufficient for transcriptional repression was identified through
the analysis of additional UL34 expression plasmids. Plasmids
coding for GAL4-DBD-UL34 fusion proteins containing
deletions or mutations were used to localize the transcriptional
regulatory domain of pUL34. We first mapped the carboxyl
terminal end of the transcriptional repressive domain using
transient transfection assays as described above. Expression of
UL34 amino acids 1 to 311 as well as amino acids 1 to 243 was
sufficient, when fused to the GAL4-DBD, to repress expression
from the US3 promoter (Fig. 3B). Deletion of an additional 11Fig. 3. Analysis of the transcriptional repressive activity ofGAL4-UL34 fusion protein
the carboxyl terminal half of pUL34. (C) Deletion analysis of the amino terminal half
proteins; reporter gene activity was measured as described in Fig. 2.amino acids, expressing only amino acids 1 to 235 as a fusion
protein, abolished the transcriptional regulatory activity of the
protein (Fig. 3B).
We also utilized theGAL4-DBD-UL34 fusion protein system
to probe the amino terminal end of the UL34 transcriptional
repressive domain. GAL4-DBD fusion proteins containing
UL34 amino acids 1 to 407, 10 to 407, or 22 to 374 fully
repressed US3 expression (Fig. 3C). In contrast, a fusion protein
containing UL34 amino acids 61–407 was unable to mediate
US3 repression (Fig. 3C).
These results mapped the amino and carboxyl terminal
boundaries of the transcriptional repressive domain to amino
acids 22 and 243, respectively, demonstrating that the amino
terminal 243 amino acids of the protein is sufficient for
transcriptional repression. Thus, when expressed as a GAL4-
DBD-UL34 fusion, the transcriptional repressive domain of
pUL34 overlaps extensively with the DNA-binding domain of
the protein. The observation that the GAL4-DBD did not repress
US3 expression (Figs. 3B and C) rules out physical protein–
DNA interactions alone as mediating repression.
Results of site-directed mutagenesis experiments confirmed
the contribution of the amino terminal half of the protein to
DNA binding and transcriptional repression. As shown in Table
1, two UL34 mutant proteins, in which amino acids G42K43
were mutated to V42A43, or where amino acids K45L46 were
mutated to N45A46, were generated to assess the contributionss. (A) Diagram of the UL34 coding region (see Fig. 1B). (B) Deletion analysis of
of pUL34. The numbers indicate the amino acids present in each of the truncated
Table 1
Amino acid substitutions in the pUL34 mutants
Plasmid Mutations
623 V312 to A; P313 to A; P314 to A; H315 to S
627 G42 to V; K43 to A
629 K45 to N; L46 to A
630 E334 to A; E335 to A
32 E. Lester et al. / Virology 353 (2006) 27–34of the conserved basic residues to pUL34-DNA-binding activity
(Fig. 4A). EMSA demonstrated that the point mutations
abolished DNA binding activity (Fig. 4B). The ability of the
mutated proteins to repress US3 expression when expressed as
GAL4-fusion proteins was assayed; neither protein was able to
repress transcription from the US3 promoter in the context of a
GAL4-binding site (Fig. 4C). These experiments demonstrated
that the amino terminal region of the protein is required for the
DNA-binding activity as well as for transcriptional repression.
In contrast, mutation of amino acids in the carboxyl terminal
half of the protein had no effect on the repressive activity of the
protein as expected, as shown for plasmids pBJ623 and pBJ630,
where proline and glutamic acid residues were mutated,
respectively (Fig. 4C and Table 1).Fig. 4. Effects of clustered site-specific mutations on activity of pUL34. (A) Wild t
reactions, and the resulting products analyzed by denaturing polyacrylamide gel elec
contains the wild type pUL34; the positions of the molecular weight markers are indi
the mutant proteins. Lane 1, probe alone; lane 2, pUL34; lanes 3 and 4, mutant prot
proteins. Plasmids encoding GAL4-DBD-UL34 fusion proteins were transfected into
has a GAL4-binding site substituted for the UL34 binding site. Reporter gene activity
mutant proteins are indicated by the single letter code.Discussion
The HCMV UL34 gene is intriguing, not only because of its
role in regulating expression of a viral immune evasion gene
(LaPierre and Biegalke, 2001) but also because expression of
the open reading frame is required for viral replication in vitro
(Murphy et al., 2004; Dunn et al., 2003; Biegalke et al., 2004).
We have identified the DNA-binding and transcriptional
regulatory domains of the UL34 open reading frame, localizing
both functions to amino acids 22 to 243. The UL34 proteins are
unusual among transcription factors, with the extensive overlap
of the DNA-binding and transcriptional regulatory domains.
The majority of transcription factors have discreet DNA-
binding and regulatory domains. Overlap of regulatory and
DNA-binding domains does occur in other proteins, however,
including proteins such as nuclear factor 90 (Reichman et al.,
2002) and v-erbA (Boucher and Privalsky, 1990). The extensive
overlap of UL34 DNA-binding and transcriptional regulatory
domains places the protein into a small group of unique
proteins.
Direct physical interaction of pUL34 with the target DNA
sequence is not required for transcriptional repression since a
protein expressing a heterologous DNA-binding domainype and mutant proteins were generated using in vitro transcription/translation
trophoresis. The amino acids mutated are indicated above lanes 1 and 2, lane 3
cated. (B) Electrophoretic mobility shift analysis of the DNA-binding activity of
eins, and lane 5, luciferase. (C) Transcriptional repressive activity of the mutant
primary human diploid fibroblasts along with the US3 reporter gene plasmid that
was measured as described in the legend to Fig. 2. The amino acid changes in the
33E. Lester et al. / Virology 353 (2006) 27–34(GAL4-DBD) fused to the UL34 open reading frame was
efficient at repressing expression of a reporter gene that
contained a GAL4-binding site in place of the pUL34 binding
site. Similarly, simple binding of a protein to the transcrip-
tional regulatory region was not sufficient for transcriptional
repression since binding of the GAL4-DBD to a GAL4-
binding site in this region had no effect on transcription.
These results suggest that the transcriptional regulatory
activity exhibited by pUL34 is most likely mediated through
protein–protein interactions rather than through steric inter-
ference with the assembly of the pol II transcription initiation
complex.
The amino terminal half of pUL34 is conserved among
the cytomegaloviruses (Liu and Biegalke, 2001). Computer
analysis predicts that the amino terminal half of the protein
will adopt a structure composed of 4 helical regions
separated by loops with disulfide bonds linking conserved
cysteine residues (Rost et al., 2004). In contrast to the
conservation seen in the amino terminal half of the UL34
homologs, the carboxyl terminal half is quite divergent and
for HCMV, pUL34 is predicted to contain intrinsically
unstructured regions (Dyson and Wright, 2005). The
conservation of the amino terminal half of pUL34 and its
homologs, coupled with the identification of predicted
multiple pUL34 binding sites within the genomes of
cytomegaloviruses, suggests that pUL34 may play additional
roles in viral replication, in addition to its role in regulating
US3 expression. Determination of the structure of the
protein, coupled with additional site-directed mutagenesis,
will be critical for advancing our understanding of the
mechanism of action of pUL34.Table 2
Oligonucleotides used for plasmid construction
Oligonucleotides
219 5′ CTCG
269 5′ AAG
270 5′ AAG
297 5′ CGTC
298 5′ GCGT
299 5′ CGCT
300 5′ CGCT
303 5′ AAG
304 5′ GGG
311 5′ CGTC
314 5′ AAG
316 5′ CCGG
319 5′ CGCG
320 5′ CGCG
321 5′ CGCG
326 5′ AAG
346 5′ ACGG
347 5′ CTTC
348 5′ GAA
349 5′ TTCT
354 5′ CGTC
355 5′ CGCG
356 5′ CCGA
357 5′ CCTC
Underlined letters indicate the position of restriction enzyme sites.Materials and methods
Tissue culture
Primary human diploid fibroblasts (HDFs) were propagated
in Dulbecco's minimal essential medium supplemented with
penicillin, streptomycin, glutamine and 10% NuSerum I
(Becton Dickinson, Bedford, MA) as described (Biegalke and
Geballe, 1990). Transient transfections were performed using
DEA–dextran, assaying the level of β-galactosidase activity by
measuring the fluorescence of the cleavage product of methyl-
umbelliferyl-β-D-galactoside (Biegalke and Geballe, 1991).
Plasmids
The plasmids described below were constructed for the
identification of the DNA domain of the UL34 proteins. Various
portions of the UL34 open reading frame were inserted into in
pBS+ (Stratagene, La Jolla, CA), with expression of the UL34
sequences transcribed under the control of the T7 promoter.
pBJ384 contains the entire early UL34 open reading frame
(LaPierre and Biegalke, 2001). The following plasmids were
used to express portions of the UL34 open reading frame using
in vitro transcription/translation reactions. pBJ501 was con-
structed from pBJ384 by digestion with SphI followed by
recircularization. pBJ544 and pBJ236 were constructed from
pBJ384 by digestion with EcoRV and HindIII or StuI and SalI,
respectively, followed by Klenow treatment and recirculariza-
tion. The following plasmids were generated by polymerase
chain amplification of the UL34 open reading frame using the
oligonucleotides listed in Table 2: pBJ567, oligonucleotidesTCGACTTAAATACACAACGGGGTTATGG 3′
GATCCTCATGAACTTCATCATCACC 3′
GATCCTCATGAACTTCATCATCACC 3′
ACCAAGAAACGCTATATATTCCGGAGGACCGTGCAGTCCACACGC 3′
GTGGACTGCACGGTCCTCCGGAATATATAGCGTTTCTTGGTGACG 3′
ATATATTCCGGAGGACTGTCCTCCGCACACGCTACTTCTCAGCG 3′
GAGAAGTAGCGTGTGCGGAGGACAGTCCTCCGGAATATATAGCG 3′
TCGACTGGAAGAGCATGCGGTAG 3′
AATTCATCATGGGCTCGATTTCCAAAGCG 3′
TAGAGGATCCACTTCTCCAACGACGATTC 3′
GATCCGCAACAGCAACCTCTTCG 3′
AATTCGAGATGCGTGACAACGTG 3′
TCGACTTAGAGGTCCGTCTTCTTC 3′
TCGACAAACAGCTCCTCTTCTTCC 3′
TCGACATCCAAACCTGAGTTCATC 3′
GATCCAGATGCGTGACAACGTGG 3′
TACGCGCCGAAGTCGCGAAGAAGCTG 3′
GGCGCGTACCGTACCCTTGTAC 3′
GGCAAGAAGAACGCGTTGCTGAAGC 3′
TCTTGCCTTCGGCGCGTACCG 3′
CCCGCACACGCGCCGCGGCTAGCGAGCAAAAGCCC 3′
TGTGCGGGGACGACGGGCGTTGC 3′
AGAAAACGAGGCTGCAGAAGAGGAGCTG 3′
GTTTTCTTCGGGCTTTTGCTCGTG 3′
34 E. Lester et al. / Virology 353 (2006) 27–34303 and 304; pBJ576, oligonucleotides 219 and 311; pBJ587,
oligonucleotides 316 and 321, pBJ588, oligonucleotides 219
and 304; and pBJ615, oligonucleotides 316 and 303. The
resulting amplimers were digested with EcoRI and SalI and
inserted into EcoRI/SalI digested pBS+ (Stratagene).
The following reporter gene plasmids were used in transient
transfection assays. pEQ3 is a promoterless plasmid that
contains the lacZ gene (Biegalke and Geballe, 1990), pBJ171
expresses the lacZ gene under the control of the US3 promoter
and transcriptional repressive element (tre; Biegalke, 1995)
and pBJ555 expresses the lacZ gene under the control of the
US3 promoter and a GAL4 DNA-binding site. pBJ555 was
constructed by mutating the tre in pBJ171 using the
QuickChange XL site-directed mutagenesis kit (Stratagene).
Two rounds of mutagenesis were used to generate pBJ555; the
first round used oligonucleotides 297 and 298 resulting in
intermediate plasmid pBJ554; the second round of mutagen-
esis used pBJ554 as a template and oligonucleotides 299 and
300 to generate pBJ555.
The following protein expression plasmids were used in
transfection assays to measure the effects of UL34 on reporter
gene expression. pEQ276 expresses IE1 and IE2, pEQ273
expresses IE1 and pEQ326 expresses IE2 (Biegalke and
Geballe, 1991). pBJ503 transcribes the UL34 open reading
frame in an anti-sense direction (LaPierre and Biegalke, 2001).
Portions of the UL34 open reading frame were expressed as
fusion proteins with the GAL4 DNA binding domain. pBJ538
expresses the GAL4 DNA-binding domain under the control of
the mIE promoter and was constructed from pBJ201 (Biegalke,
1997). pBJ201 was modified to remove the unique BamHI site
by digestion, Klenow treatment and ligation, resulting in
pBJ531. A DNA fragment containing the GAL4 DNA-binding
domain was isolated from pGBT9 (Clontech Laboratories, Palo
Alto, CA) using HindIII and inserted into the HindIII site of
pBJ531. UL34 fragments were prepared by polymerase chain
reaction (see Table 2 for sequences of the oligonucleotides); the
resulting amplimers were digested with BamHI and SalI and
inserted into the BamHI and SalI sites of pBJ538. pBJ569 was
constructed using oligonucleotides 269 and 219; pBJ577 with
311 and 219; pBJ578 with 314 and 219, and pBJ593 with 326
and 319. pBJ641, pBJ642 and pBJ653 were constructed by
MluI/SalI, StuI/SalI or EcoRV/SalI digestion, respectively, of
pBJ569 followed by Klenow treatment and ligation. pBJ623,
627, 629 and 630 contain specific point mutations inserted
using the Gene Tailor Site-Directed mutagenesis kit (Invitrogen,
Carlsbad, CA) and the indicated oligonucleotides: pBJ623,
oligonucleotides 354 and 355; pBJ627, oligonucleotides 346
and 347; pBJ629, oligonucleotides 348 and 349; and pBJ630,
oligonucleotides 356 and 357. The open reading frames of the
UL34 expression plasmids were sequenced.
Electrophoretic mobility shift assays (EMSAs)
EMSAs were performed essentially as described, synthesiz-
ing UL34 proteins by in vitro transcription/translation reactionsand assaying the ability of the resulting proteins to retard the
migration of a radiolabeled DNA fragment containing the UL34
binding site in the US3 gene, the tre (LaPierre and Biegalke,
2001).Acknowledgments
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